Proficio Capital Partners LLC bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, Holdings Channel.com reports. The firm bought 36,360 shares of the company’s stock, valued at approximately $4,672,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Frazier Financial Advisors LLC acquired a new position in Merck KGaA during the second quarter worth about $25,000. Rakuten Securities Inc. purchased a new position in Merck KGaA in the 2nd quarter worth approximately $27,000. Solstein Capital LLC purchased a new position in Merck KGaA in the 2nd quarter worth approximately $33,000. Delos Wealth Advisors LLC purchased a new position in Merck KGaA in the 2nd quarter worth approximately $33,000. Finally, Burk Holdings LLC acquired a new position in shares of Merck KGaA during the 2nd quarter worth approximately $39,000. 0.10% of the stock is owned by hedge funds and other institutional investors.
Merck KGaA Price Performance
MKGAF stock opened at $164.58 on Thursday. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a market capitalization of $21.27 billion, a PE ratio of 25.13 and a beta of 0.96. The business has a 50 day simple moving average of $163.19 and a 200-day simple moving average of $148.83.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
